1,200
Participants
Start Date
November 1, 2021
Primary Completion Date
May 31, 2022
Study Completion Date
May 31, 2024
Myovista® WavECG™
The MyoVista wavECG Device uses wavelet signal processing to extract frequency information from the acquired 12-lead ECG signal which is then analysed using artificial intelligence to provide information relating to left ventricular relaxation abnormalities
Great Western Hospitals NHS Foundation Trust, Swindon
Great Western Hospitals NHS Foundation Trust, Swindon
Collaborators (1)
Royal Cornwall Hospitals Trust
OTHER
Northern Care Alliance NHS Foundation Trust
OTHER
North Tees and Hartlepool NHS Foundation Trust
OTHER
Riverside Medical Center
OTHER
HeartSciences Inc, USA
UNKNOWN
Great Western Hospitals NHS Foundation Trust
OTHER